Daiichi Sankyo Co Ltd (DSNKY)
32.20
+1.34
(+4.34%)
USD |
OTCM |
Apr 26, 16:00
Daiichi Sankyo Gross Profit (Quarterly): 2.182B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.182B |
December 31, 2023 | 2.198B |
September 30, 2023 | 1.944B |
June 30, 2023 | 1.874B |
March 31, 2023 | 1.698B |
December 31, 2022 | 1.720B |
September 30, 2022 | 1.757B |
June 30, 2022 | 1.586B |
March 31, 2022 | 1.249B |
December 31, 2021 | 1.663B |
September 30, 2021 | 1.622B |
June 30, 2021 | 1.634B |
March 31, 2021 | 1.339B |
December 31, 2020 | 1.635B |
September 30, 2020 | 1.478B |
June 30, 2020 | 1.438B |
March 31, 2020 | 1.266B |
December 31, 2019 | 1.823B |
September 30, 2019 | 1.316B |
June 30, 2019 | 1.468B |
March 31, 2019 | 1.153B |
December 31, 2018 | 1.401B |
September 30, 2018 | 1.249B |
June 30, 2018 | 1.293B |
March 31, 2018 | 1.186B |
Date | Value |
---|---|
December 31, 2017 | 1.534B |
September 30, 2017 | 1.382B |
June 30, 2017 | 1.431B |
March 31, 2017 | 994.57M |
December 31, 2016 | 1.667B |
September 30, 2016 | 1.440B |
June 30, 2016 | 1.512B |
March 31, 2016 | 1.276B |
December 31, 2015 | 1.572B |
September 30, 2015 | 1.354B |
June 30, 2015 | 1.356B |
March 31, 2015 | 1.031B |
December 31, 2014 | 1.527B |
September 30, 2014 | 1.440B |
June 30, 2014 | 1.460B |
March 31, 2014 | 848.24M |
December 31, 2013 | 1.855B |
September 30, 2013 | 1.797B |
June 30, 2013 | 1.671B |
March 31, 2013 | 1.529B |
December 31, 2012 | 2.156B |
September 30, 2012 | 2.090B |
June 30, 2012 | 2.195B |
March 31, 2012 | 2.199B |
December 31, 2011 | 2.180B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.249B
Minimum
Mar 2022
2.198B
Maximum
Dec 2023
1.644B
Average
1.635B
Median
Gross Profit (Quarterly) Benchmarks
AstraZeneca PLC | 10.46B |
Eisai Co Ltd | 998.97M |
Takeda Pharmaceutical Co Ltd | 4.956B |
Nxera Pharma Co Ltd | 37.53M |
PeptiDream Inc | 20.24M |